RankAlpha logo
Back to Rankings

LPCN

LipocineA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
A timely Verity launch and rigorous BLOOM execution could improve the case for TLANDO royalties and LPCN 1154. Lipocine said its existing resources should support BLOOM, subject to study costs and duration [#SEC-8K-2026-09-14].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
BLOOM may repeat the earlier Phase 3 primary-endpoint failure despite revised site controls.
Momentum
100
Value
57
Sentiment
63
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.60 · Bull $2.50 · Bear $0.70Analysis 2026-10-24; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-24 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-26

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions

Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $5.00
Why
Momentum100 · Δ7d -
Value57 · Δ7d -0.2
Sentiment63 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Sentiment remains the lead driver in the composite.

Contradictions & invalidation

  • • BLOOM may repeat the earlier Phase 3 primary-endpoint failure despite revised site controls.
  • • Canadian TLANDO launch execution and royalty materiality depend on Verity Pharma; approval alone does not establish demand [#8-K-2026-10-07].
  • • The prior LPCN 1154 Phase 3 trial missed its primary endpoint in the full analysis set.

Catalyst clock

2026-12-31

First dosing in BLOOM

Lead driver: Sentiment · See AI snapshot
Momentum
100
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
57
47% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-1.0
Sentiment
63
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade A. Momentum 99.5 / Value 56.7 / Sentiment 62.6

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-24. Scenario method

B+
Bull case
25%
Probability
Target price
$2.50
Analysis reference price unavailable
Analysis 2026-10-24 · RankAlpha Sentiment Codex
Most likely
B
Base case
45%
Probability
Target price
$1.60
Analysis reference price unavailable
Analysis 2026-10-24 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.70
Analysis reference price unavailable
Analysis 2026-10-24 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$11.95M
Beta
0.99
Shares Out
8.24M
P/E (TTM) · Derived
-0.8
P/S (TTM)
9.38
P/FCF (TTM) · Derived
-0.82
Rev YoY
-69.5%
EPS YoY
-22.5%
Gross Margin
+96.3%
Op Margin
-800.8%
Net Debt
-$14.93M
Current Ratio
11.48
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data